DMAC

DiaMedica Therapeutics Inc.

Healthcare · Biotechnology

$287.59 sample

-2.59 (-0.89%) 1D

Market cap

$1.30T

Price as of

2026-10-15

Latest filing

8-K · 2026-10-13

Alerts

8

Price$287.59 +4.75% 3M daily closessample

314.87270.67

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 13SEC8-K filed: material event
Oct 07SECForm 144 filed
Sep 28SECDEF 14A filed
Sep 21INSInsider sell: Chief Executive Officer
Sep 16INSInsider buy: EVP, Operations
Sep 09INSInsider sell: 10% owner
Sep 04INSInsider sell: EVP, Operations
Sep 01SEC8-K filed: material event

Sign up to see the real DMAC record →

Company facts

SEC EDGAR registration

Name: DiaMedica Therapeutics Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +33sample, -100 to +100
Reporting currency: USD

Who is positioning in DMAC

sample

Insiders: 31 insider transactions over 90 days, net selling, $46.0M
Congress: 1 members traded over 90 days
Institutions · 13F: 25 funds hold $22.2B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$40.8B +21.8% y/y

Q4 2024Q3 2026

Inventory$23.2B +8.8% y/y

Q4 2024Q3 2026

Accounts receivable$17.6B +7.5% y/y

Q4 2024Q3 2026

Total debt$49.6B +13.0% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $783.4B +6.5% 3M
Sample peer B: $202.1B +5.9% 3M
Sample peer C: $1.10T -8.7% 3M
Sample peer D: $334.6B -5.0% 3M
Sample peer E: $1.02T -12.1% 3M